Myrbetriq
Payments companies reported to CMS as associated with Myrbetriq. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Myrbetriq, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Myrbetriq
These are the largest totals companies reported as associated with Myrbetriq. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Sandip Vasavada | Cleveland, OH | Urology | $21,158.17 |
| Elaine Urbina | Cincinnati, OH | Pediatric Cardiology | $7,892.00 |
| Molly Fuchs | Columbus, OH | Pediatric Urology | $6,330.00 |
| Israel Franco | New Haven, CT | Pediatric Urology | $4,387.50 |
| Beth Drzewiecki | Boston, MA | Pediatric Urology | $4,056.18 |
| Philip Walson | Cincinnati, OH | Clinical Pharmacology | $2,775.00 |
| Jeffrey Small | Bridgeport, CT | Urology | $375.79 |
| David Miller | Middletown, OH | Urology | $357.51 |
| Martin Walsh | Middletown, OH | Urology | $336.18 |
| Matthew Lemer | White Plains, NY | $333.16 |
Prescribed Myrbetriq?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.